MOXONIDINE IN THE TREATMENT OF ARTERIAL HYPERTENSION: EFFICIENCY IN COMBINATION THERAPY AND ADDITIONAL INDICATIONS


L.O. Minushkina

FSBI "Education and Research Medical Center" of the Administrative Department of the President of the Russian Federation, Moscow
Blood pressure cannot be controlled in 20-30% of patients, even against the background of receiving a combination of 3-4 drugs from major groups. In the pathogenesis of arterial hypertension (AH), activation of the sympathetic nervous system (SNS) plays an important role. Antihypertensive medications with central action help to reduce tone of SNS nuclei. Moxonidine belongs to this group of antihypertensive drugs. The article presents the data on the antihypertensive efficacy of moxonidine, and potentials for the combination therapy of arterial hypertension. The literature data on the impact of moxonidine on carbohydrate metabolism and insulin sensitivity are discussed. Potential benefits of use of this drug in patients with overweight, metabolic syndrome, diabetes, as well as in elderly patients and postmenopausal women are demonstrated. Data on organoprotective features of moxonidine - effects on endothelial function, microalbuminuria, and cardiac hypertrophy – are analyzed.

About the Autors


L.O. Minushkina – MD, Prof. at the Department of Therapy and Functional Diagnostics with the course of Nephrology FSBI "Education and Research Medical Center" of the Administrative Department of the President of the Russian Federation; e-mail: minushkina@mail.ru


Similar Articles


Бионика Медиа